BlackRock Fund Advisors - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2016$90,000
+80.0%
38,641
+28.8%
0.00%
Q3 2016$50,000
+78.6%
30,001
+11.8%
0.00%
Q2 2016$28,000
-99.2%
26,842
-99.3%
0.00%
-100.0%
Q1 2016$3,499,000
-29.6%
4,021,172
-2.1%
0.00%0.0%
Q4 2015$4,970,000
-27.4%
4,107,485
+1.9%
0.00%
-50.0%
Q3 2015$6,850,000
-16.8%
4,029,311
+1.7%
0.00%0.0%
Q2 2015$8,237,000
-8.1%
3,960,332
+19.7%
0.00%0.0%
Q1 2015$8,965,000
+7.5%
3,307,971
+2.0%
0.00%0.0%
Q4 2014$8,337,000
+61.9%
3,243,777
+15.3%
0.00%
+100.0%
Q3 2014$5,150,000
-33.5%
2,813,980
-2.9%
0.00%
-50.0%
Q2 2014$7,741,000
-30.3%
2,899,286
-8.6%
0.00%
-33.3%
Q1 2014$11,105,000
-19.3%
3,172,823
+3.1%
0.00%
-25.0%
Q4 2013$13,763,000
+6.2%
3,078,300
-3.6%
0.00%0.0%
Q3 2013$12,963,000
+10.9%
3,192,935
+13.6%
0.00%0.0%
Q2 2013$11,690,0002,810,0210.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders